Author

R. T. Carback

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

R. M. Rubsamen· 3 shared C. V. Herst· 2 shared L. Wang· 2 shared P. E. Harris· 2 shared S. Burkholz· 2 shared S. Massey· 2 shared T. Brasel· 2 shared T. Hodge· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. M. Rubsamen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintJul 25, 2022

Survivin (BIRC5) peptide vaccine in the 4T1 murine mammary tumor model: a potential neoadjuvant T-cell immunotherapy for triple negative breast cancer.

S. R. Burkholz, C. V. Herst, R. T. Carback…·R. M. Rubsamen

This study evaluates a survivin peptide vaccine in a 4T1 murine model, showing slower tumor growth and a gamma IFN Elispot response in vaccinated mice.

DOI 10.1101/2022.07.25.501455

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivJun 20, 2020

Anti-IL-6 versus Anti-IL-6R BlockingAntibodies to Treat Acute Ebola Infection inBALB/c Mice: Potential Implications forTreating Cytokine Release Syndrome

R. M. Rubsamen, S. Burkholz, S. Massey…·P. Harris

This study shows that early IL-6 neutralization with an anti-IL-6 mAb improves outcomes in Ebola-infected mice, suggesting potential benefits for treating cytokine release syndrome.

DOI 10.3389/fphar.2020.574703

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivFeb 25, 2020

An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors' CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design

C. V. Herst, S. Burkholz, J. Sidney…·R. M. Rubsamen

The paper identifies a conserved Ebola Zaire epitope that provides protection in mice and suggests its potential application in COVID-19 vaccine design.

DOI 10.1016/j.vaccine.2020.04.034

mouseproteomics

𝕏 PostBluesky